1 - 25 of
37
results
for author:"Louis D.N."
in Literature Citations
| MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. Yip S., Miao J., Cahill D.P., Iafrate A.J., Aldape K., Nutt C.L., Louis D.N. Clin. Cancer Res. 15:4622-4629(2009) · Mapped (6) |
| MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. Cahill D.P., Codd P.J., Batchelor T.T., Curry W.T., Louis D.N. Clin Neurosurg 55:165-171(2008) · Mapped (6) |
| Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Stegh A.H., Kesari S., Mahoney J.E., Jenq H.T., Forloney K.L., Protopopov A., Louis D.N., Chin L., DePinho R.A. Proc. Natl. Acad. Sci. U.S.A. 105:10703-10708(2008) · Mapped (5) |
| Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. de la Iglesia N., Konopka G., Lim K.L., Nutt C.L., Bromberg J.F., Frank D.A., Mischel P.S., Louis D.N., Bonni A. J. Neurosci. 28:5870-5878(2008) · Mapped (8) |
| Patterns of somatic mutation in human cancer genomes. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C. et al. Nature 446:153-158(2007) · UniProtKB (453) |
| Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Ligon K.L., Huillard E., Mehta S., Kesari S., Liu H., Alberta J.A., Bachoo R.M., Kane M., Louis D.N., Depinho R.A. et al. Neuron 53:503-517(2007) · Mapped (9) |
| In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. Riemenschneider M.J., Mueller W., Betensky R.A., Mohapatra G., Louis D.N. Am. J. Pathol. 167:1379-1387(2005) · Mapped (9) |
| YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Nutt C.L., Betensky R.A., Brower M.A., Batchelor T.T., Louis D.N., Stemmer-Rachamimov A.O. Clin. Cancer Res. 11:2258-2264(2005) · Mapped (4) |
| Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas. Mizoguchi M., Nutt C.L., Mohapatra G., Louis D.N. Brain Pathol. 14:372-377(2004) · Mapped (6) |
| Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Plummer N.W., Gallione C.J., Srinivasan S., Zawistowski J.S., Louis D.N., Marchuk D.A. Am. J. Pathol. 165:1509-1518(2004) · Mapped (51) |
| CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. Sloan K.E., Eustace B.K., Stewart J.K., Zehetmeier C., Torella C., Simeone M., Roy J.E., Unger C., Louis D.N., Ilag L.L. et al. BMC Cancer 4:73-73(2004) · UniProtKB (1) |
| Lung cancer: intragenic ERBB2 kinase mutations in tumours. Stephens P., Hunter C., Bignell G., Edkins S., Davies H., Teague J., Stevens C., O'Meara S., Smith R., Parker A. et al. Nature 431:525-526(2004) · Mapped (8) |
| The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. Ligon K.L., Alberta J.A., Kho A.T., Weiss J., Kwaan M.R., Nutt C.L., Louis D.N., Stiles C.D., Rowitch D.H. J. Neuropathol. Exp. Neurol. 63:499-509(2004) · Mapped (3) |
| Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G. et al. N. Engl. J. Med. 350:2129-2139(2004) · Mapped (15) |
| The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer. Yang C., Ionescu-Tiba V., Burns K., Gadd M., Zukerberg L., Louis D.N., Sgroi D., Schmidt E.V. Am. J. Pathol. 164:1031-1038(2004) · Mapped (4) |
| Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Okada Y., Hurwitz E.E., Esposito J.M., Brower M.A., Nutt C.L., Louis D.N. Cancer Res. 63:413-416(2003) · Mapped (31) |
| Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms. Heinrich B., Hartmann C., Stemmer-Rachamimov A.O., Louis D.N., MacCollin M. Int. J. Cancer 103:483-488(2003) · Mapped (9) |
| Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Weiss W.A., Israel M., Cobbs C., Holland E., James C.D., Louis D.N., Marks C., McClatchey A.I., Roberts T., Van Dyke T. et al. Oncogene 21:7453-7463(2002) · Mapped (35) |
| Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Mueller W., Hartmann C., Hoffmann A., Lanksch W., Kiwit J., Tonn J., Veelken J., Schramm J., Weller M., Wiestler O.D. et al. Am. J. Pathol. 161:313-319(2002) · Mapped (31) |
| Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Xiao A., Wu H., Pandolfi P.P., Louis D.N., Van Dyke T. Cancer Cell 1:157-168(2002) · Mapped (4) |
| Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas. Hartmann C., Johnk L., Sasaki H., Jenkins R.B., Louis D.N. Brain Pathol. 12:178-182(2002) · Mapped (6) |
| DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis. Sasaki H., Betensky R.A., Cairncross J.G., Louis D.N. Cancer Res. 62:1790-1796(2002) · Mapped (5) |
| Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Lu Q.R., Park J.K., Noll E., Chan J.A., Alberta J.A., Yuk D.-I., Alzamora M.G., Louis D.N., Stiles C.D., Rowitch D.H. et al. Proc. Natl. Acad. Sci. U.S.A. 98:10851-10856(2001) · UniProtKB (2) |
| Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability. Lu X., Magrane G., Yin C., Louis D.N., Gray J., Van Dyke T. Mol. Cell. Biol. 21:6017-6030(2001) · Mapped (10) |
| ANOVA, a putative astrocytic RNA binding protein gene that maps to chromosome 19q13.3. Ueki K., Ramaswamy S., Billings S.J., Mohrenweiser H.W., Louis D.N. Neurogenetics 1:31-36(1997) · UniProtKB (1) |
